Translating cell and gene therapies to the clinic

The translation of cell and gene therapy products requires significant resources, knowledge, experience, and infrastructure. Even with vast resources, the path forward is often non-linear, confusing, and cumbersome. Here we review the process by which to take a cell or gene therapy product from discovery into a phase 1 clinical trial in the academic setting.

Submitted for peer review: 25 Oct 2018 Published: 19 Dec 2018

Please enter your email to access content Read now